Oct 29 2009
Biotechnology is an emerging industry to which many countries are attaching great importance. China is determined to grasp the great opportunities brought by the biotechnology revolution. Biotech industry will become a pillar of China’s hi-tech sector, in which bio-pharmaceutical is playing a leading role.
How do pharmaceutical companies understand medicine pricing administration? How to maximize the achievement after the success of R&D? How do we select the products with high potentials while popular products are playing a bigger role? In the China Bio-pharmaceutical Summit 2009 (Dec. 10th -11th, Shanghai China), the above mentioned questions will be answered thoroughly.
This event features the theme of “boosting industry integration and innovation through in-depth interpretation of policies and market landscape; focusing on industry milestones of 2009”, so as to enhance the high-level exchange between bio-pharmaceutical enterprises, research institutes, contractors, relevant service providers and investment institutions, etc.
The Bacterin Day on Dec. 11th will highlight topics on bacterin technologies, vaccine transportation and testing, advice on legal and investment issues, etc. This session will help the delegates better understand the vaccine market.